Wanbury Ltd - 524212 - Update on board meeting
Wanbury's Board Meeting, initially scheduled for May 14, 2026, has been postponed and rescheduled to May 29, 2026. The meeting will consider and approve the audited standalone financial results for the fourth quarter and full financial year ended March 31, 2026.
May 12 2026 17:05:00
Wanbury Limited
Wanbury's Board will convene on May 14, 2026, to consider and approve the audited standalone yearly financial results. These results pertain to the financial year ending March 2026.
May 05 2026 18:05:00
Wanbury Ltd - 524212 - Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of The Company For The Fourth Quarter And Year Ended 31St March, 2026.
Wanbury's Board is scheduled to meet on May 14, 2026, to consider and approve the audited financial results for Q4 FY26 and the full financial year. This meeting will finalize the company's financial performance for the last fiscal period.
May 05 2026 18:05:00
Wanbury Limited
Wanbury Limited's Patalganga site successfully completed its MFDS (Korea FDA) regulatory inspection with zero observations, confirming cGMP compliance. This follows prior zero observations from USFDA and Anvisa (Brazil FDA) for its API manufacturing sites.
Apr 28 2026 17:04:00
Wanbury Limited
Wanbury's FY26 Secretarial Compliance Report indicated non-compliance with SEBI regulations, specifically regarding delayed shareholding pattern submission and various board/committee composition requirements. The company incurred significant fines for these breaches and has since taken remedial actions, including new director appointments.
Apr 24 2026 18:04:00
Read More